Related references
Note: Only part of the references are listed.ADAMTS1, a putative anti-angiogenic factor, is decreased in human prostate cancer
Helene Gustavsson et al.
BJU INTERNATIONAL (2009)
The effect of thrombospondin-1 on breast cancer metastasis
Karen O. Yee et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Prospective Study of Prostate Tumor Angiogenesis and Cancer-Specific Mortality in the Health Professionals Follow-Up Study
Lorelei A. Mucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts
K. Welen et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2009)
ADAMTS-1 Metalloproteinase Promotes Tumor Development through the Induction of a Stromal Reaction In vivo
Natacha Rocks et al.
CANCER RESEARCH (2008)
Altered expression of genes regulating angiogenesis in experimental androgen-independent prostate cancer
Helene Gustavsson et al.
PROSTATE (2008)
Angiotensin II type I receptor antagonist as an angiogenic inhibitor in prostate cancer
Takeo Kosaka et al.
PROSTATE (2007)
ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2
Nathan V. Lee et al.
EMBO JOURNAL (2006)
Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity
Karin Jennbacken et al.
PROSTATE (2006)
Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively
YJ Liu et al.
ONCOGENE (2006)
Metalloproteinases and their inhibitors in tumor angiogenesis
MM Handsley et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis
H Gustavsson et al.
PROSTATE (2005)
Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease
G Di Lorenzo et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2005)
U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3
Ekwere T. Ifon et al.
CANCER CELL INTERNATIONAL (2005)
Is tumor vascularity in prostate core biopsies a predictor of PSA recurrence after radical prostatectomy?
A Khatami et al.
ACTA ONCOLOGICA (2005)
Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma
S Porter et al.
CLINICAL CANCER RESEARCH (2004)
The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potential
K Kuno et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer
C Vallbo et al.
BJU INTERNATIONAL (2004)
Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation
DL Russell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165
A Luque et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mechanisms of normal and tumor-derived angiogenesis
M Papetti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor
JC Rodríguez-Manzaneque et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
